Please login to the form below

Not currently logged in
Email:
Password:

Bayer Healthcare

This page shows the latest Bayer Healthcare news and features for those working in and with pharma, biotech and healthcare.

PMEA 2016 finalists announced

PMEA 2016 finalists announced

PMEA 2016 finalists announced. AbbVie, Bayer, Celgene and Novartis are up for the prestigious Company of the Year.

Latest news

  • Bayer confirms bid for Monsanto; will pharma suffer? Bayer confirms bid for Monsanto; will pharma suffer?

    Bayer confirms bid for Monsanto; will pharma suffer? Analysts fear agrochemical $62bn deal will hinder its medicines business. ... close to the $25bn posted by Bayer's entire healthcare division last year, and much larger than its $15bn pharma business.

  • Bayer picks strategy head for top post Bayer picks strategy head for top post

    Baumann joined Bayer in 1988, working initially in the corporate finance department in Leverkusen. ... He then served as chief financial officer, chief strategy and portfolio officer and chairman of the board of management of Bayer HealthCare.

  • Bayer restructures its operations, drops Bayer Healthcare group Bayer restructures its operations, drops Bayer Healthcare group

    Bayer restructures its operations, drops Bayer Healthcare group. Will instead have divisions for pharmaceuticals, consumer health and crop science. ... As part of the reorganisation, the Bayer HealthCare subgroup will be dissolved as each division will

  • Bayer sells diabetes division to Panasonic Healthcare Bayer sells diabetes division to Panasonic Healthcare

    Bayer sells diabetes division to Panasonic Healthcare. 1.02bn sale includes Contour electronic meters and other medical devices. ... Bayer has sold its diabetes care division to distribution partner Panasonic Healthcare for 1.02bn, in keeping with the

  • Quality in Care anticoagulation programme open for entry Quality in Care anticoagulation programme open for entry

    The Quality in Care (QiC) anticoagulation programme is now open for entry to recognise the work carried out by healthcare professionals who improve care for those using anticoagulation therapy in the ... UK. The programme is supported in 2015 by Bayer

More from news
Approximately 3 fully matching, plus 133 partially matching documents found.

Latest Intelligence

  • Shaping healthcare Shaping healthcare

    Shaping healthcare. Bayer’s Lars Bruening talks about moving to the UK as the market works its way through a series of seismic changes. ... Coming back to value, how do  you measure Bayer’s impact on the healthcare system and on patients in the UK?

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    Working with our healthcare system more closely is vital. Bayer’s Lars Bruening on partnership working amid environmental challenges. ... I am determined that this continues to be the way that Bayer works with the NHS.

  • Sustainable solutions Sustainable solutions

    Sustainable solutions. Bayer's Alex Moscho on working towards long-term answers in healthcare. ... The question of healthcare systems change is also very much on his mind when we talk, and clearly it's an important issue from a Bayer perspective.

  • How Bayer transformed its approach to digital How Bayer transformed its approach to digital

    As part of the reorganisation, the Bayer HealthCare subgroup will be dissolved as each division will focus on core competencies close to its businesses – R&D, production, and sales and marketing. ... regulatory affairs operations manager for Bayer

  • Pharma deals in June 2015 Pharma deals in June 2015

    Halozyme has several case studies to validate its technology and these illustrate the greater convenience and associated reduction in overall healthcare costs that are possible. ... Collaboration, licence. 1, 170. Bayer Diabetes Care/ Panasonic Healthcare

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

  • Andy Busch joins Shire as its CSO and head of research and development Andy Busch joins Shire as its CSO and head of research and development

    Busch, who is currently head of drug discovery for Bayer, where he leads a team of approximately 3, 300 researchers. ... During his 13 years at Bayer he held several roles, including senior vice president, head discovery Europe at Bayer Healthcare and

  • Neovii Pharmaceuticals promotes Juergen Pohle to CEO Neovii Pharmaceuticals promotes Juergen Pohle to CEO

    Pohle has served as Neovii’s chief commercial officer of Pharmaceuticals since 2016 and has over 25 years of experience in the pharmaceutical industry, having previously worked at Bayer HealthCare, GlaxoSmithKline

  • Werner Baumann to replace Brandicourt at Bayer Werner Baumann to replace Brandicourt at Bayer

    Werner Baumann has been named as the new chairman at Bayer Healthcare, replacing Olivier Brandicourt who departs from the firm on April 2. ... Commenting on Brandicourt's departure, Dekkers added: “ I would like to thank Olivier Brandicourt for his

  • Bayer's Kirstyn Nicholas joins Spirit Healthcare Bayer's Kirstyn Nicholas joins Spirit Healthcare

    Bayer's Kirstyn Nicholas joins Spirit Healthcare. Takes up role as regional business director. ... The role included working with CCG leads, consultants and clinical scientists and prior to that she worked as healthcare development manager at Bayer

  • Catalent appoints two board members Catalent appoints two board members

    Jack Stahl, former CEO of cosmetics firms Revlon, and Rolf Classon, former chairman at Bayer Healthcare, will use to their experience to advise Catalent, a leading player in providing drug development, ... Classon served as chairman at Bayer Healthcare

More from appointments
Approximately 2 fully matching, plus 18 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics